Skip to main content
Premium Trial:

Request an Annual Quote

Danish Government Awards $1.6M to MicroRNA Research Consortium

NEW YORK, May 1 (GenomeWeb News) - Danish drug developer Santaris Pharma said today that it has created a MicroRNA Research Consortium in partnership with the Department for Medical Biochemistry and Genetics at the University of Copenhagen.


The new consortium is partially supported by a €1.3 million ($1.6 million) grant from the the Danish Advanced Technology Foundation. This will be matched by an additional €1.3 million from the University of Copenhagen and Santaris Pharma.


The consortium's first goal will be "to target microRNAs involved in human cancer and develop effective drugs that block their action," Santaris said.


The University will have the first right to patent new drug targets discovered in the partnership and Santaris will be responsible for the development and commercialization of antagonists of these targets as potential new cancer drugs.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.